Eric Drape - 08 Feb 2022 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role: Executive VP Global Operations
Signature: /s/ Dov Bergwerk as attorney-in-fact for Eric Drape
Issuer symbol: TEVA
Transactions as of: 08 Feb 2022
Net transactions value: -$32,464
Form type: 4
Filing time: 10 Feb 2022, 15:08:25 UTC
Previous filing: 25 May 2021
Next filing: 02 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TEVA	Ordinary Shares	Options Exercise		+6,568	+20%		39,696	09 Feb 2022	Direct	F1, F2
transaction	TEVA	Ordinary Shares	Sale	$32,464	-3,583	-9%	$9.06	36,113	09 Feb 2022	Direct	F1, F3, F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TEVA	Restricted Share Units	Options Exercise	$0	-6,568	-100%	$0.000000^*	0	09 Feb 2022	Ordinary Shares	6,568		Direct	F2, F6
transaction	TEVA	Restricted Share Units	Award	$0	+32,518		$0.000000	32,518	08 Feb 2022	Ordinary Shares	32,518		Direct	F2, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2	Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3	The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F4	Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.
F5	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.06 to $9.075, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
F6	Restricted share units were granted on February 9, 2018, with 6,567 having vested on each of February 9, 2020 and February 9, 2021 and 6,568 having vested on February 9, 2022.
F7	Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 4, 2022.